• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23488 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     Malaysian Health Technology Assessment (MaHTAS) Vitamin C Injection for Cosmetic
2012     HAYES, Inc. Vitamin D and breast cancer
2009     Agency for Healthcare Research and Quality (AHRQ) Vitamin D and calcium: a systematic review of health outcomes
2014     Agency for Healthcare Research and Quality (AHRQ) Vitamin D and calcium: a systematic review of health outcomes (update)
2012     HAYES, Inc. Vitamin D supplementation and risk of fractures, falls, and bone loss
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D supplementation in long-term care residents: clinical evidence and guidelines
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Vitamin D supplementation in patients with active or latent tuberculosis
2012     HAYES, Inc. Vitamin D supplementation in patients with osteoporosis
2014     NIHR Health Technology Assessment programme Vitamin D supplementation in pregnancy: a systematic review
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infection: individual patient data meta-analysis of randomised controlled trials
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2020     Swiss Federal Office of Public Health (FOPH) Vitamin D testing
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing for northern populations: clinical and cost-effectiveness and guidelines
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: a review of the clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2009     NIHR Health Technology Assessment programme Vitamin K to prevent fractures in older women: a systematic review and economic evaluation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin supplementation for hospitalized adults: clinical evidence and guidelines
2013     Agency for Healthcare Research and Quality (AHRQ) Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2015     National Institute for Health and Care Excellence (NICE) VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions. NICE diagnostics guidance 19
2016     NIHR Health Technology Assessment programme VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation
2009     HAYES, Inc. Vivitrol (Injectable Naltrexone) (Alkermes Inc.) for outpatient treatment of alcohol dependence
2008     HAYES, Inc. ViziLite Plus with TBlue (Zila Inc.) as an adjunct to conventional oral mucosal screening for high-risk patients
2007     Adelaide Health Technology Assessment (AHTA) VNS therapy system for the treatment of depression
2005     Adelaide Health Technology Assessment (AHTA) VNS Therapy(TM) System for the treatment of chronic or recurrent treatment-resistant depression in adults
2012     Malaysian Health Technology Assessment (MaHTAS) VNUS® Radiofrequency Ablation (RFA) for varicose vein
2014     HAYES, Inc. Vocal fold steroid injection for treatment of dysphonia
2004     Adelaide Health Technology Assessment (AHTA) Vocera (R) wireless communication
2008     NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin (LX-211) for non-infectious uveitis
2008     NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin for moderate to severe plaque psoriasis
2023     National Institute for Health and Care Excellence (NICE) Voclosporin with mycophenolate mofetil for treating lupus nephritis. NICE technology appraisal guidance 882
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Voice controlled arthroscopic pump
2016     NIHR Horizon Scanning Centre (NIHR HSC) Voke 0.45mg inhaler for smoking cessation – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Volanesorsen - familial chylomicronemia syndrome – first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Volasertib for acute myeloid leukaemia in patients ineligible for intensive induction therapy – first line
2024     Scottish Health Technologies Group (SHTG) Volatile capture technologies
2005     The Swedish Council on Health Technology Assessment (SBU) Volume and quality - a preliminary study
2019     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Volume-outcome relationships: pancreaticoduodenectomy (Whipple procedure). Final report
2014     HAYES, Inc. Von Hippel-Lindau (VHL) syndrome
2011     HAYES, Inc. von Willebrand Factor (VWF) gene testing for von Willebrand Disease (VWD)
2016     NIHR Horizon Scanning Centre (NIHR HSC) Vonicog alfa for severe von Willebrand disease
2020     Agency for Care Effectiveness (ACE) Vonoprazan for treating helicobacter pylori infection
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for acute coronary syndrome
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for secondary prevention of cardiovascular events
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations (package advice)
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Voriconazole
2008     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat (Zolinza) for cutaneous T-cell lymphoma - second line
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat for refractory multiple myeloma
2015     NIHR Health Technology Assessment programme Vortioxetine for treating major depressive disorder
2015     National Institute for Health and Care Excellence (NICE) Vortioxetine for treating major depressive episodes. NICE technology appraisal guidance 367
2012     NIHR Horizon Scanning Centre (NIHR HSC) Vosaroxin in combination with cytarabine for acute myeloid leukamaemia
2024     National Institute for Health and Care Excellence (NICE) Voxelotor for treating haemolytic anaemia caused by sickle cell disease. NICE technology appraisal guidance 981
2013     HAYES, Inc. VPRIV (Velaglucerase Alfa for Injection; Shire Human Genetic Therapies Inc.) for type 1 gaucher disease
2022     Penn Medicine Center for Evidence-based Practice (CEP) VTE chemoprophylaxis for patients undergoing elective spinal surgery
2023     National Institute for Health and Care Excellence (NICE) Vutrisiran for treating hereditary transthyretin-related amyloidosis. NICE technology appraisal guidance 868
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. 2: selected divisions of the departments of medicine and surgery. Supplement to report no 26 "Wait times at the MUHC 1"
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. I: diagnostic imaging, joint replacement, cancer care, sight restoration, cardiac care
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 3 fracture management.
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 4 Diagnostic imaging revisited. Adult hospitals of the MUHC.
2006     VA Technology Assessment Program (VATAP) Wait times for primary hip and knee replacement surgery
2007     Centre Hospitalier de l'Universite de Montreal(CHUM) Waiting times at CHUM 1: diagnostic imaging, hip and knee replacements,cardiac surgery, cancer care and sight restoration
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Ward rounds - a health technology assessment focused on production of knowledge
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Warm-up therapy
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Warming of amniofluid: safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Watchful dosing of morphine or morphine equivalent dosing in the treatment of chronic non-cancer pain: a review of the clinical evidence
2009     NIHR Horizon Scanning Centre (NIHR HSC) WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2013     Malaysian Health Technology Assessment (MaHTAS) Water birth
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Water jet systems for surgical dissection and resection
2002     HAYES, Inc. Water-induced thermotherapy (WIT) for benign prostatic hyperplasia
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Waterless wipes for chemical eye injuries: clinical effectiveness
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Wavefront analysis in refractive surgery
2015     NIHR Horizon Scanning Centre (NIHR HSC) WavSTAT4 Optical Biopsy System® for colorectal cancer diagnosis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Wear compliance and donning/doffing of respiratory protection for bioaerosols or infectious agents: a review of the effectiveness, safety, and guidelines
2009     Adelaide Health Technology Assessment (AHTA) Wearable artificial kidney (WAK): Portable dialysis for patients with chronic kidney disease
2022     Austrian Institute for Health Technology Assessment (AIHTA) Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest. Update 2022
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2016     European Network for Health Technology Assessment (EUnetHTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Update 2018
2010     Blue Cross Blue Shield Association (BCBS) Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment
2022     Health Technology Wales (HTW) Wearable cardioverter-defibrillators for people at risk of cardiac death
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Web-based toolkit to facilitate European collaboration on evidence generation on promising health technologies
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) WEBLING project: full text web indexes that have been linguistically enhanced and supplemented by services to cross the language barrier (internal report). In cooperation with EU ESPRIT program. IPE-01/i (Internal Report)
2010     Quality Improvement Scotland (NHS QIS ) Weight management programmes for adults
2008     Penn Medicine Center for Evidence-based Practice (CEP) Weight-based dosing nomograms for unfractionated heparin
2010     NIHR Health Technology Assessment programme Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project
2005     NIHR Health Technology Assessment programme Wessex Epidural Steroids Trial (WEST), primary research
2013     Scottish Health Technologies Group (SHTG) What approaches have been taken and efforts made to ensure public involvement in decision making relating to potential disinvestment in healthcare interventions and technologies?
2002     New Zealand Health Technology Assessment (NZHTA) What are the characteristics of repeating vs. non-repeating suicidal presenters to Emergency services? Evidence Tables
2006     NIHR Health Technology Assessment programme What are the clinical outcome and cost-effectiveness of endoscopy undertaken by nurses when compared with doctors? A Multi-Institution Nurse Endoscopy Trial (MINuET)
2015     NIHR Health Services and Delivery Research programme What are the determinants of variations in emergency readmission rates and one-year mortality in patients hospitalized with heart failure or chronic obstructive pulmonary disease?
2002     New Zealand Health Technology Assessment (NZHTA) What are the presenting complaints that should alert clinicians in emergency departments and tertiary mental health settings to the possibility of suicidal ideation/threat/attempts? Evidence Tables
2015     Belgian Health Care Knowledge Centre (KCE) What are the recommended clinical assessment and screening tests during pregnancy?
2009     Health Services Assessment Collaboration (HSAC) What assessment tools are used both in New Zealand and in other countries for grading of evidence?
2017     NIHR Health Technology Assessment programme What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial
2002     New Zealand Health Technology Assessment (NZHTA) What clinical features best determine insulin resistance? Evidence Tables
2009     Institute for Clinical Evaluative Sciences (ICES) What does it take to make a healthy province? A benchmark study of jurisdictions in Canada and around the world with the highest levels of health and the best health behaviours
2006     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) What effects has the cataract surgery on the development and progression of age-related macular degeneration (AMD)?
2002     New Zealand Health Technology Assessment (NZHTA) What evidence exists about the safety of physical restraint when used by law enforcement and medical staff to control individuals with acute behavioural disturbance?
2002     New Zealand Health Technology Assessment (NZHTA) What evidence is there about the use of seclusion or containment for patients presenting with suicidal behaviours at emergency departments, tertiary mental health services or inpatient units? Evidence Tables